Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$5.05 - $8.85 $83,466 - $146,272
-16,528 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.03 - $11.7 $132,719 - $193,377
16,528 New
16,528 $138,000
Q3 2019

Nov 14, 2019

SELL
$9.05 - $12.22 $149,062 - $201,275
-16,471 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.75 - $13.03 $144,121 - $214,617
16,471 New
16,471 $177,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $183M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.